Valproic	valproic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
encephalopathy--19	encephalopathy--19	O	O	O	O
new	new	O	O	O	O
cases	cases	O	O	O	O
in	in	O	O	O	O
Germany	germany	O	O	O	O
from	from	O	O	O	O
1994	1994	O	O	O	O
to	to	O	O	O	O
2003	2003	O	O	O	O
-	-	O	O	O	O
-a	-a	O	O	O	O
side	side	O	O	O	O
effect	effect	O	O	O	O
associated	associated	O	O	O	O
to	to	O	O	O	O
VPA-therapy	vpa-therapy	O	O	O	O
not	not	O	O	O	O
only	only	O	O	O	O
in	in	O	O	O	O
young	young	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

Valproic	valproic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
broad-spectrum	broad-spectrum	O	O	O	O
antiepileptic	antiepileptic	O	O	O	O
drug	drug	O	O	O	O
and	and	O	O	O	O
is	is	O	O	O	O
usually	usually	O	O	O	O
well-tolerated	well-tolerated	O	O	O	O
.	.	O	O	O	O

Rare	rare	O	O	O	O
serious	serious	O	O	O	O
complications	complications	O	O	O	O
may	may	O	O	O	O
occur	occur	O	O	O	O
in	in	O	O	O	O
some	some	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
including	including	O	O	O	O
haemorrhagic	haemorrhagic	O	O	OTHERS	I
pancreatitis	pancreatitis	O	O	OTHERS	I
,	,	O	O	O	O
bone	bone	O	DISEASE	OTHERS	I
marrow	marrow	O	DISEASE	OTHERS	I
suppression	suppression	O	DISEASE	OTHERS	I
,	,	O	O	O	O
VPA-induced	vpa-induced	O	O	O	O
hepatotoxicity	hepatotoxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
VPA-induced	vpa-induced	O	O	O	O
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
typical	typical	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
VPA-induced	vpa-induced	O	O	O	O
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
are	are	O	O	O	O
impaired	impaired	O	O	OTHERS	I
consciousness	consciousness	O	O	OTHERS	I
,	,	O	O	O	O
sometimes	sometimes	O	O	O	O
marked	marked	O	O	O	O
EEG	eeg	O	O	O	O
background	background	O	O	O	O
slowing	slowing	O	O	O	O
,	,	O	O	O	O
increased	increased	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
frequency	frequency	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
or	or	O	O	O	O
without	without	O	O	O	O
hyperammonemia	hyperammonemia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

There	there	O	O	O	O
is	is	O	O	O	O
still	still	O	O	O	O
no	no	O	O	O	O
proof	proof	O	O	O	O
of	of	O	O	O	O
causative	causative	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
only	only	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
association	association	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
assumed	assumed	O	O	O	O
causal	causal	O	O	O	O
relation	relation	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
19	19	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
VPA-associated	vpa-associated	O	O	O	O
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
Germany	germany	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
years	years	O	O	O	O
1994	1994	O	O	O	O
to	to	O	O	O	O
2003	2003	O	O	O	O
,	,	O	O	O	O
none	none	O	O	O	O
of	of	O	O	O	O
whom	whom	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
published	published	O	O	O	O
previously	previously	O	O	O	O
.	.	O	O	O	O

